SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-17-002040
Filing Date
2017-01-26
Accepted
2017-01-26 19:26:08
Documents
2
Period of Report
2017-01-26

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 6548
2 EX-24 DOCUMENT attachment1.htm EX-24 3694
  Complete submission text file 0000899243-17-002040.txt   11575
Mailing Address 40 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address
TEPPER ROBERT I (Reporting) CIK: 0001192595 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37998 | Film No.: 17551351

Mailing Address 1030 MASSACHUSETTS AVE. CAMBRIDGE MA 02138
Business Address 1030 MASSACHUSETTS AVE. CAMBRIDGE MA 02138 857-259-3840
Jounce Therapeutics, Inc. (Issuer) CIK: 0001640455 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)